![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
FXR AGONISM BY GS-9674 DECREASES
STEATOSIS AND FIBROSIS IN A MURINE
MODEL OF NASH
|
|
|
Reported by Jules Levin
EASL 2016 Nov 11-15 Boston, MA
J.T. Liles1, S. Karnik1, E. Hambruch2, C. Kremoser2, M. Birkel2,
W. J. Watkins1, D. Tumas1, D. Breckenridge1, D. French1
PS066: Friday 15 April 2016
1Gilead Sciences, Foster City, United States;
2Phenex Pharmaceuticals AG, Heidelberg, Germany
![HCV1](../images/120216/120216-3/HCV1.gif)
![HCV2](../images/120216/120216-3/HCV2.gif)
![HCV3](../images/120216/120216-3/HCV3.gif)
![HCV4](../images/120216/120216-3/HCV4.gif)
![HCV5](../images/120216/120216-3/HCV5.gif)
![HCV6](../images/120216/120216-3/HCV6.gif)
![HCV7](../images/120216/120216-3/HCV7.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|